Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Freudenberg

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|August 5, 2003
Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-upL S Freudenberg, G Antoch, T Beyer, et al.
Nuklearmedizin. Nuclear Medicine|October 18, 2006
[Evil radioactivity. Subjective perception of radioactivity in patients with thyroid disease prior to treatment with radioiodine]L S Freudenberg, T Beyer, S P Müller, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2007
124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancerL S Freudenberg, W Jentzen, R J Marlowe, et al.
Nuklearmedizin. Nuclear Medicine|August 11, 2007
124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impactL S Freudenberg, W Jentzen, R Görges, et al.
Der Urologe. Ausg. A|November 28, 2008
[Impact of nuclear medicine imaging techniques for lymph node surgery]L S Freudenberg, G Holl, S P Müller, et al.
Nuklearmedizin. Nuclear Medicine|May 22, 2008
Somatostatin receptor scintigraphy in advanced renal cell carcinoma. Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCCL S Freudenberg, T Gauler, R Görges, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2008
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PETL S Freudenberg, G Antoch, A Frilling, et al.
European Radiology|January 11, 2003
Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomographyL S Freudenberg, S J Rosenbaum, J Schulte-Herbrüggen, et al.
Survey of Ophthalmology|August 25, 2004
Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanomaL S Freudenberg, A O Schueler, T Beyer, et al.
Nuklearmedizin. Nuclear Medicine|January 6, 2006
Prognostic value of c-erbB-2 expression in papillary thyroid carcinomaL S Freudenberg, S Sheu, R Görges, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|August 5, 2003
Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-upL S Freudenberg, G Antoch, T Beyer, et al.
Nuklearmedizin. Nuclear Medicine|October 18, 2006
[Evil radioactivity. Subjective perception of radioactivity in patients with thyroid disease prior to treatment with radioiodine]L S Freudenberg, T Beyer, S P Müller, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2007
124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancerL S Freudenberg, W Jentzen, R J Marlowe, et al.
Nuklearmedizin. Nuclear Medicine|August 11, 2007
124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impactL S Freudenberg, W Jentzen, R Görges, et al.
Der Urologe. Ausg. A|November 28, 2008
[Impact of nuclear medicine imaging techniques for lymph node surgery]L S Freudenberg, G Holl, S P Müller, et al.
Nuklearmedizin. Nuclear Medicine|May 22, 2008
Somatostatin receptor scintigraphy in advanced renal cell carcinoma. Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCCL S Freudenberg, T Gauler, R Görges, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2008
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PETL S Freudenberg, G Antoch, A Frilling, et al.
European Radiology|January 11, 2003
Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomographyL S Freudenberg, S J Rosenbaum, J Schulte-Herbrüggen, et al.
Survey of Ophthalmology|August 25, 2004
Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanomaL S Freudenberg, A O Schueler, T Beyer, et al.
Nuklearmedizin. Nuclear Medicine|January 6, 2006
Prognostic value of c-erbB-2 expression in papillary thyroid carcinomaL S Freudenberg, S Sheu, R Görges, et al.
Pageof 3